Table 1.
Study | Design | Country | Location | NOS | Age (Mean, y/o) | Sample Size | Outcome | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mortality | ICU | MV | AKI | KRT | Graft Loss | |||||||
Abolghasemi [19] | RC | Iran | Multi-center | 6 | 49 | 24 | 10 | 12 | NR | NR | NR | NR |
Abrishami [20] | RC | Iran | Single-center | 5 | 47.6 | 12 | 8 | 10 | 9 | NR | NR | NR |
Akalin [21] | RC | USA | Single-center | 5 | 36 | 60 | 10 | NR | 11 | NR | 6 | NR |
Alberici [22] | RC | Italy | Single-center | 5 | 59 | 20 | 5 | 4 | 0 | 6 | 1 | NR |
Azzi [23] | PC | USA | Single-center | 5 | 59 | 229 | 47 | NR | NR | NR | NR | NR |
Azzi [23] | PC | USA | Single-center | 5 | 61 | 79 ## | NR | NR | 28 | 18 | 18 | 5 |
Banerjee [24] | RC | UK | Multi-center | 6 | 57.4 | 7 | 1 | 4 | 2 | 4 | 3 | NR |
Bell [25] | RC | Scotland (Scottish Renal Registry) | Multi-center | 7 | NR | 24 | 7 | NR | NR | NR | NR | NR |
Benotmane [26] | RC | France | Single-center | 5 | 62.2 | 49 | 9 | 14 | 2 | 31 | 4 | NR |
Bossini [27] | RC | Italy | Multi-center | 6 | 60 | 53 | 15 | 10 | 9 | 15 | 3 | NR |
Caillard [28] | RC | France (nationwide registry) | Multi-center | 6 | 60.8 | 279 | 43 | 88 | 72 | 106 | 27 | 9 |
Chavarot [29] | RC | France | Multi-center | 7 | 64.7 | 100 | 26 | 34 | 29 | NR | NR | NR |
Chen [30] | RC | USA | Single-center | 5 | 56 | 30 | 6 | NR | 7 | NR | 4 | NR |
Coll [31] | RC | Spain | Multi-center | 6 | 62 | 423 | 103 | 57 | 36 | NR | NR | NR |
Craig-Schapiro [32] | RC | USA, NY | Single-center | 6 | 57 | 80 | 13 | NR | 16 | 25 | 4 | 4 |
Cravedi [33] | RC | USA | Multi-center | 6 | 60 | 144 | 46 | NR | 42 | 74 | NR | NR |
Cristelli [34] | PC | Brazil | Single-center | 5 | 53 | 491 | 140 | NR | 156 | 229 | 155 | NR |
Demir [35] | RC | Turkey | Multi-center | 6 | 44.9 | 40 | 5 | 7 | 6 | 14 | NR | NR |
Devresse [36] | PC | USA | Single-center | 5 | 57 | 22 | 2 | 2 | 2 | 5 | 0 | NR |
Dheir [37] | RC | Turkey | Single-center | 5 | 48 | 20 | 2 | NR | 2 | 5 | 2 | NR |
Elec [38] | RC | Romania | Single-center | 5 | 52 | 42 | 7 | 8 | NR | 10 | N | NR |
Elhadedy [39] | RC | UK | Multi-center | 6 | 50.1 | 8 | 0 | 1 | 1 | 2 | 1 | 0 |
Elias [40] | PC | France | Multi-center | 7 | 56.4 | 66 | 16 | 15 | 15 | 28 | 7 | NR |
Favà [41] | RC | Spain | Multi-center | 6 | 59.7 | 104 | 28 | NR | 14 | 47 | NR | NR |
Fernández-Ruiz [42] | RC | Spain | Single-center | 5 | 69.1 | 8 | 2 | 0 | 0 | NR | NR | NR |
Georgery [43] | RC | Belgium | Single-center | 5 | 60.6 | 45 | 8 | 14 | 14 | NR | NR | NR |
Gupta [44] | PC | India | Single-center | 5 | 44.5 | 10 | 1 | NR | NR | NR | NR | NR |
Hardesty [45] | RC | USA | Single-center | 6 | 55 | 11 | 1 | NR | 3 | 1 | 1 | NR |
Hilbrands [46] | PC | Europe, ERACODA collaboration | Multi-center | 7 | 60 | 305 | 65 | 57 | 49 | 30+ | 30 | NR |
Husain [47] | RC | USA, NY (Columbia University Vagelos College of Physicians and Surgeons) | Single-center | 5 | 51 | 15 | 2 | NR | 4 | 6 | NR | NR |
Jager [48] | PC | Europe, ERA-EDTA Registry | Multi-center | 7 | 60.9 | 1013 | 191 | NR | NR | NR | NR | NR |
Katz-Greenberg [49] | RC | USA, Philadelphia | Single-center | 5 | 52.5 | 20 | 3 | NR | 4 | 9 | 1 | 1 |
Kumaresan [50] | RC | India | Single-center | 5 | 49.7 | 16 | 3 | NR | 3 | 1 | 1 | NR |
Kute [51] | RC | India | Multi-center | 6 | 43 | 250 | 29 | 53 | 30 | 121 | 24 | 12 |
Lubetzky [52] | RC | USA | Single-center | 5 | 57 | 54 | 7 | NR | 11 | 21 | 3 | 3 |
Lum [53] | RC | USA | Single-center | 5 | 48.5 | 41 | 4 | 9 | 8 | 11 | 4 | 1 |
Mamode [54] | RC | UK | Multi-center | 5 | 56.2 | 121 | 36 | 30 | 22 | NR | 19 | 15 |
Maritati [55] | RC | Italy | Single-center | 5 | 66 | 5 | 2 | NR | 3 | 1 | 1 | NR |
Meester [56] | PC | Belgium (NBVN Kidney Registry Group) | Multi-center | 7 | NR | 43 | 6 | NR | NR | NR | NR | NR |
Mella [57] | RC | Italy | NR | 5 | 55.5 | 6 | 4 | NR | 2 | NR | NR | NR |
Meziyerh [58] | RC | Netherlands | Single-center | 5 | 56 | 15 | 6 | 6 | 5 | NR | NR | NR |
Mohamed [59] | PC | UK | Single-center | 6 | 57 | 28 | 9 | 5 | NR | 14 | 2 | NR |
Molaei [60] | RC | Iran | Single-center | 5 | 59.6 | 10 | 2 | 4 | 4 | 7 | NR | NR |
Monfared [61] | RC | Iran | Single-center | 5 | 52 | 22 | 6 | NR | 5 | 12 | NR | NR |
Montagud-Marrahi [62] | RC | Spain | Single-center | 5 | 57.1 | 33 | 2 | 13 | 2 | NR | NR | 1 |
Nair [63] | RC | USA, NY | Single-center | 5 | 57 | 10 | 3 | 5 | 4 | 5 | 1 | NR |
Oto [64] | RC | Turkey | Multi-center | 6 | 48.4 | 109 | 14 | 22 | 19 | 46 | 4 | NR |
Ozturk [65] | RC | Turkey | Multi-center | 7 | 48 | 81 | 9 | 17 | 14 | NR | NR | NR |
Phanish [66] | RC | UK | Multi-center | 7 | 62 | 23 | 6 | 9 | 6 | 13 | 4 | 2 |
Pierrotti [67] | RC | Brazil | Single-center | 5 | 51.9 | 51 | 13 | 23 | 17 | 30 | 19 | 0 |
Rodriguez-Cubillo [68] | RC | Spain | Single-center | 5 | 66 | 24 | 6 | NR | 5 | 14 | 3 | 0 |
Sandes-Freitas [69] | RC | Brazil (National registry) | Multi-center | 6 | 53.9 | 8 | 3 | 4 | 4 | 4 | 4 | 2 |
Santeusanio [70] | RC | USA | Single-center | 5 | 43.8 | 38 | 11 | NR | 14 | 22 | 12 | 12 |
Shrivastava [71] | RC | USA | Single-center | 5 | 61.5 | 38 | 9 | 13 | 9 | 27 | 6 | NR |
Tejada [72] | RC | USA, Detroit Medical Center | Single-center | 5 | 56 | 25 | 1 | 4 | 1 | 16 | NR | NR |
Trujillo [73] | RC | Spain | Single-center | 5 | 54 | 10 | 3 | NR | 0 | 8 | NR | NR |
Villa [74] | RC | Germany | Single-center | 6 | 62 | 7 | 3 | NR | 3 | 4 | NR | NR |
Villanego [75] | PC | Spain (prospectively filled registry) | Multi-center | 6 | 60 | 1011 | 220 | 140 | NR | NR | NR | NR |
Willicombe [76] | RC + PC # | UK, London | Single-center | 5 | 56 | 113 | 17 | NR | NR | NR | NR | NR |
Zhu [77] | RC | China | Multi-center | 6 | 45 | 10 | 1 | NR | 0 | 6 | 0 | NR |
# Including a seroprevalence survey and clinical cohort; ## Sub-cohort report different outcomes other than mortality; abbreviations: AKI, Acute kidney injury; ICU, intensive care unit; KRT, kidney replacement therapy; MV, mechanical ventilation, NOS, Newcastle–Ottawa Scale; NR: not reported; PC, prospective cohort/case series; RC, retrospective cohort/case series.